跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Glaxosmithkline Trading Services Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 30, 2024
Approval ID
5707f8c622306c95
Company
Glaxosmithkline Trading Services Limited
Type
Standard
Approval Details
Approval Id
5707f8c622306c95
Drug Cima Aemps Name
OMJJARA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1231782001
Holder Company Name
Glaxosmithkline Trading Services Limited
Marketing Company Name
Glaxosmithkline S.A.
Holder Company Detail Path
/organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path
/organization/glaxosmithkline-sa
Authorization Date
2024-01-30
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Glaxosmithkline Trading Services Limited
Company Detail Path
/organization/glaxosmithkline-trading-services-limited
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE TRADING SERVICES LIMITED
Country Name
Spain
City Name
madrid,madrid,country_es
Address
PASEO CASTELLANA 11
Active Ingredients
MOMELOTINIB DIHIDROCLORURO MONOHIDRATO
121,94 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 30, 2024
Approval ID
5707f8c622306c95
Type
Standard
Back to CIMA-AEMPS Approvals